← Healthspan Infrastructure research Healthspan · H8 · Rejuvenate / Repair

Rejuvenate / Repair stocks

By Scott McLeodPublished by PXS Research Updated September 12, 2026

Frontier longevity therapies, repair biology, organ manufacturing and rejuvenation platforms.

7 mapped stocks0 company-level buy signals4 technologies

H8 capability map

Rejuvenate / Repair technologies

Open a technology to understand the capability, evidence framework and every directly mapped public stock.

Gene and Cell Therapy Platforms

0 stocks mapped · Open research Deep Dive

Organ Preservation & Bioengineering

2 stocks mapped · Open research Deep Dive

Partial Cellular Reprogramming — Cost Per Dose Economics

4 stocks mapped · Open research Deep Dive

Partial Cellular Reprogramming & Senescence Reversal

0 stocks mapped · Open research

Rejuvenate / Repair stock picks

NTLAIntellia TherapeuticsIn-vivo CRISPR Rejuvenate / Repair WATCH●●●○○ ●●●○○ $16.07Research target 9/12/26Last reviewed CRSPCRISPR TherapeuticsCRISPR gene editing Rejuvenate / Repair WATCH●●●●○ ●●●●○ $63.14Research target 9/5/26Last reviewed TMDXTransMedicsEx-vivo organ perfusion & transplant logistics Rejuvenate / Repair WATCH●●○○○ ●●○○○ $104.45Research target 8/31/26Last reviewed PRMEPrime MedicinePrime editing Rejuvenate / Repair WATCH●●●●○ ●●●●○ $7.65Research target 8/29/26Last reviewed TWSTTwist BioscienceDNA synthesis Rejuvenate / Repair WATCH●●○○○ ●●○○○ $176.98Research target 8/29/26Last reviewed BEAMBeam TherapeuticsBase editing Rejuvenate / Repair WATCH●●●●○ ●●●●○ $61.14Research target 7/31/26Last reviewed UTHRUnited TherapeuticsXenotransplantation, manufactured organs Rejuvenate / Repair WATCH●●●●● ●●●●● $663.21Research target 7/8/26Last reviewed

Funds investing in